COLL

Collegium Pharmaceutical Stock Price

19.10
0.00 (0.0%)
19.10
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Collegium Pharmaceutical Inc COLL NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 19.10 04:00:00
Close Price Low Price High Price Open Price Previous Close
19.10
Bid Price Ask Price Spread News
18.52 19.58 1.06 - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 19.10 USD

Collegium Pharmaceutical Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 659.44M 34.53M 29.64M $ 296.70M $ 8.19M -0.67 80.53
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% -16.61k 2.40%

more financials information »

Collegium Pharmaceutical News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical COLL Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week20.9421.3918.6319.62220,888-1.84-8.79%
1 Month17.5122.5217.5120.70294,6231.599.08%
3 Months16.2922.5215.6619.11334,1052.8117.25%
6 Months20.6424.31915.6619.23370,541-1.54-7.46%
1 Year11.4425.6011.1919.75475,6357.6666.96%
3 Years11.7429.909.0118.54477,4367.3662.69%
5 Years16.9130.587.3717.20402,9122.1912.95%

Collegium Pharmaceutical Description

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. It is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing and dissolving. Its product Xtampza ER, is an abuse-deterrent, extended-release, oral formulation of oxycodone.


Your Recent History
NASDAQ
COLL
Collegium ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.